Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Boehringer Ingelheim Pharmaceuticals |
---|---|
Information provided by: | Boehringer Ingelheim Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00133185 |
The primary objective of this trial is to compare the efficacy and safety of telmisartan 40 mg/hydrochlorothiazide 12.5mg (Micardis Plus) with that of losartan 50 mg/hydrochlorothiazide 12.5 mg, a reference AIIA combined with diuretic, in Taiwanese patients with mild to moderate hypertension.
Condition | Intervention | Phase |
---|---|---|
Hypertension |
Drug: telmisartan 40 mg/hydrochlorothiazide 12.5 mg Drug: losartan 50 mg/hydrochlorothiazide 12.5 mg |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40 mg + HCTZ 12.5 mg in Comparison With Losartan 50mg + HCTZ 12.5 mg in Taiwanese Patients With Mild to Moderate Hypertension |
Estimated Enrollment: | 40 |
Study Start Date: | March 2004 |
Estimated Study Completion Date: | January 2005 |
Ages Eligible for Study: | 20 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 502.406 |
Study First Received: | August 22, 2005 |
Last Updated: | March 2, 2009 |
ClinicalTrials.gov Identifier: | NCT00133185 History of Changes |
Health Authority: | Taiwan: Department of Health |
Losartan Clotrimazole Benzoates Miconazole Diuretics Sodium Chloride Symporter Inhibitors Tioconazole Vascular Diseases Cardiovascular Agents Antihypertensive Agents |
Angiotensin II Hydrochlorothiazide Protease Inhibitors Angiotensin II Type 1 Receptor Blockers Antifungal Agents Angiotensin-Converting Enzyme Inhibitors Telmisartan Anti-Arrhythmia Agents Hypertension |
Anti-Infective Agents Losartan Molecular Mechanisms of Pharmacological Action Benzoates Diuretics Physiological Effects of Drugs Sodium Chloride Symporter Inhibitors Vascular Diseases Enzyme Inhibitors Cardiovascular Agents Antihypertensive Agents Hydrochlorothiazide |
Pharmacologic Actions Protease Inhibitors Angiotensin II Type 1 Receptor Blockers Membrane Transport Modulators Natriuretic Agents Antifungal Agents Therapeutic Uses Angiotensin-Converting Enzyme Inhibitors Cardiovascular Diseases Anti-Arrhythmia Agents Telmisartan Hypertension |